Study finds cancer guidelines do not fully meet IOM standards

In an age when evidence-based care is increasingly important, how trustworthy are current clinical practice guidelines?

Researchers at the University of Michigan Comprehensive Cancer Center looked at 169 cancer for lung, breast, prostate and and found that none of the guidelines fully met standards set in 2011 by the Institute of Medicine. Of eight criteria, the guidelines on average met fewer than three.

"None of the current guidelines we looked at meet all of the standards, but some of these are really good guidelines. It begs the question: How pragmatic are the Institute of Medicine standards? In some ways, are these standards too strict?" says lead study author Sandra Wong, M.D., M.S., associate professor of surgery at the University of Michigan Medical School.

The IOM standards for clinical practice guidelines were developed to ensure that guidelines truly reflect the best quality of care. The standards cover eight criteria, including disclosing , using systematic reviews of the literature, seeking external review and updating recommendations regularly.

In this new study, published in the Journal of Clinical Oncology, researchers reviewed guidelines for the four leading causes of cancer deaths – lung, colorectal, breast and . Guidelines covered recommendations for screening, diagnosis, treatment or follow-up care.

On average, guidelines met 2.75 of 8 major criteria and 8.24 of 20 sub-criteria. The most common gaps were in managing and including patients or other lay people in the process.

"The IOM was trying to define what you need to have trustworthy guidelines. But if a group does not include a forum for public comment on the guidelines, does that make the guideline less trustworthy? Is that as important as whether they incorporate a systematic review of the literature? One consideration is that perhaps all standards should not be weighted the same across the board," Wong says.

She also suggests creating a balance between ideal standards and what is practical to ensure guidelines can be put in place in a timely manner. Some guidelines already take more than a year to create.

"Everybody is much more worried about quality standards and evidence based care. Clinicians are inundated with a lot of information and must be able to rely on guidelines produced by major professional organizations. At the same time, standards must ensure a practical and pragmatic approach to creating ," Wong says.

More information: Journal of Clinical Oncology, DOI: 10.1200/JCO.2012.46.8371

add to favorites email to friend print save as pdf

Related Stories

New statement released by anticoagulation forum

May 31, 2013

(HealthDay)—The Anticoagulation Forum has endorsed a new consensus statement aimed at optimizing the delivery of anticoagulation therapy to inpatients; the statement has been published in the May issue ...

RARE-Bestpractices: Researching rare diseases

Apr 01, 2013

Clinical research needs to optimise its agenda by taking into consideration both patients' and clinicians' needs and interests. This is the goal of a four-year project funded by the EU's Seventh Framework ...

Recommended for you

Pepper and halt: Spicy chemical may inhibit gut tumors

7 hours ago

Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin – the active ingredient in chili peppers – produces chronic activation of a receptor on cells lining ...

Expressive writing may help breast cancer survivors

9 hours ago

Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the University of Houston (UH).

Taking the guesswork out of cancer therapy

15 hours ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

16 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

16 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

User comments